Inozyme Pharma
INZY
$0.82
Share price
-6.20%
Change (1 day)
-87.35%
Change (1 year)
Categories
EPS for Inozyme Pharma (INZY)
EPS in 2023 (TTM): -$1.55
According to Inozyme Pharma's latest financial reports the company's current EPS (TTM) is -$1.55. In 2022 the company made an earnings per share (EPS) of -$1.89 a decrease over its 2021 EPS that were of -$1.77.
EPS history for Inozyme Pharma from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.55 | -17.99% |
| 2022 | -$1.89 | 6.78% |
| 2021 | -$1.77 | -41.04% |
| 2020 | -$3.00 | 130.75% |
| 2019 | -$1.30 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$2.18 | 40.65% | 🇺🇸 USA |